R2p Misago
Payments companies reported to CMS as associated with R2p Misago. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with R2p Misago, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with R2p Misago
These are the largest totals companies reported as associated with R2p Misago. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sameh Sayfo | Plano, TX | Interventional Cardiology | $6,702.21 |
| William Beckerman | New Brunswick, NJ | Vascular Surgery | $3,541.60 |
| Mohammad Ansari | Lubbock, TX | Interventional Cardiology | $2,700.00 |
| Ankur Lodha | Lafayette, LA | Interventional Cardiology | $2,424.08 |
| Edvard Skripochnik | Bronx, NY | Vascular Surgery | $1,831.02 |
| Marcelo Guimaraes | Charleston, SC | Vascular & Interventional Radiology | $1,488.28 |
| Constantino Pena | Miami, FL | Diagnostic Radiology | $1,200.00 |
| Eric Fishman | Purchase, NY | Vascular Surgery | $1,150.00 |
| Thomas O'Donnell | New York, NY | Vascular Surgery | $957.67 |
| Suroosh Marzban | Cortlandt Manor, NY | Vascular Surgery | $942.86 |
Prescribed R2p Misago?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.